• 10 ways ASCs can counteract rising supply costs

    Seemingly endless supply disruptions, rising costs of supplies and labor and decreasing reimbursements are just some of the challenges ASCs have to contend with in 2024.
  • Business students tackle Piedmont's ASC problem

    Atlanta-based Piedmont Hospital recently tasked a group of business students with determining how the hospital could stop losing so much of its surgical business to ASCs in the area, according to a Feb. 2 report from Technique.
  • HCA continues to target ASCs in 2024

    Nashville, Tenn.-based HCA Healthcare set its sights on outpatient care in 2023 — and based on the health system's recent activity, 2024 is no different. 
  • How 1 ASC is preparing for cyberattacks

    Healthcare-related cyberattacks are on the rise in the U.S., with more than 51.9 million patient records being exposed in 2022 alone. 
  • Why Kentucky is the worst place for physicians to retire

    Kentucky has been named the worst state to retire in for 2024 by personal finance website WalletHub, followed by New Jersey and Mississippi. 
  • Good news, bad news for ASCs in 2024

    Here are four pieces of good news and three pieces of bad news affecting the ASC industry at the moment. 
  • Healthcare cut 4,182 jobs in January

    There were 4,182 healthcare/product industry layoffs in January, up 421% from the 802 cuts announced in December, according to a Feb. 1 report by executive coaching firm Challenger, Gray & Christmas.
  • Cardiologist vs. GI vs. orthopedist pay: Key comparisons to know

    The national average annual salary earned by cardiologists, gastroenterologists and orthopedic surgeons varies by $72,000 according to Medscape's 2023 compensation reports. 
  • 5 things to know about Optum's ASC powerhouse

    Here are five things to know about SCA Health, Optum's ASC arm:
  • The lowest-paying physician specialties in the last 5 years

    While physician salaries are on the rise, pediatric and public health specialists consistently rank as the lowest earners, according to Medscape compensation reports. 
  • Federal Reserve to hold interest rates steady

    The Federal Reserve will hold interest rates steady amid high consumer confidence and a falling inflation rate, according to a Jan. 31 report from NBC News.
  • 15 sentenced in $40M fraud, physician kickback scheme 

    Fifteen people were sentenced in connection with a $40 million insurance scam in California in which a telemarketing company pushed prescriptions and medical devices to patients. 
  • 2 physicians charged in university athletics billing scheme

    Two physicians, along with two other individuals, were indicted by a grand jury on charges of federal violations connected to a university athletics department billing scheme.
  • US medical board invalidates some exam scores

    The United States Medical Licensing Examination board is invalidating exam results for a group of exam-takers following irregular patterns in exam performance. 
  • 3 physicians suing former employers 

    Here are three physicians who have filed suits against their former employers since Nov. 15:
  • January sees lowest hiring month on record

    U.S. companies saw the highest level of job cuts in January since early 2023 and the lowest planned hiring level for the month since 2009, according to a Feb. 1 report from CNBC.
  • 5 ASC giants by number of physicians

    ASCs nationwide are stepping up physician recruitment efforts to further their growth. 
  • Home health company owner sentenced for $2.8M fraud scheme

    Home health company owner Yogesh Pancholi, 43, was sentenced to nine years in prison for a nearly $2.8 million healthcare fraud and wire fraud scheme. 
  • Medical lab operator sentenced to prison for $234M Medicare con

    A California medical lab operator was sentenced to 10 years in prison for conspiring to conceal his role in a billing scheme that defrauded Medicare of approximately $234 million.
  • Why physicians advise a 'wait and see' approach to weight loss drugs

    Glucagon-like peptide 1 receptor agonists are rapidly growing in popularity, with prescriptions for Ozempic and similar drugs quadrupling in less than three years, according to a September report from The Washington Post. 

Featured Webinars

Featured Whitepapers

Featured Podcast